MBRX
USDMoleculin Biotech Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$0.483
Максимум
$0.502
Минимум
$0.470
Объем
2.28M
Фундаментальные показатели компании
Рыночная капитализация
24.6M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
4.00M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia "MIRACLE" Clinical Trial at the 14th Annual Acute Leukemia Meeting
HOUSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat
Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer
Atlantic Health, a leading provider of health care based in New Jersey, to conduct the investigator-initiated Phase 1B/2 study Preclinical studies indicate Annamycin targets key factors in pancreatic cancer HOUSTON,
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Equity InsiderNews Commentary – Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms,...
Связанные акции
HOFVW
Hall of Fame Resort & Entertainment Company Warrant
XELB
Xcel Brands Inc.
FGB
First Trust Specialty Finance and Financial Opportunities Fund
FDBC
Fidelity D & D Bancorp Inc.
KZIA
Kazia Therapeutics Limited American Depositary Shares
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.